Vascular tumors are abnormal growths that develop in the blood vessels, ranging from benign hemangiomas to malignant angiosarcomas. Research into vascular tumors focuses on understanding their molecular mechanisms, identifying biomarkers for early detection, and developing targeted therapies. Recent studies have uncovered genetic mutations and signaling pathways implicated in their formation, providing potential targets for drug intervention. Advanced imaging techniques such as MRI and CT scans aid in accurate diagnosis and monitoring tumor progression. Immunotherapy and anti-angiogenic drugs show promise in treating aggressive vascular tumors by disrupting blood vessel formation and targeting tumor cells. Collaborative efforts between oncologists, geneticists, and pharmacologists are essential for advancing treatment strategies and improving outcomes for patients with vascular tumors.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States